288 related articles for article (PubMed ID: 11096287)
1. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
3. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
[TBL] [Abstract][Full Text] [Related]
4. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity.
Capasso G; Rosati C; Ciani F; Giordano DR; Russo F; De Santo NG
Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
[TBL] [Abstract][Full Text] [Related]
8. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
9. Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.
Peyroux J; Beslot F; Claperon N; Fournie-Zaluski MC; Roques BP
Br J Pharmacol; 1995 Dec; 116(8):3117-24. PubMed ID: 8719785
[TBL] [Abstract][Full Text] [Related]
10. Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.
Webb RL; Yasay GD; McMartin C; McNeal RB; Zimmerman MB
J Cardiovasc Pharmacol; 1989 Aug; 14(2):285-93. PubMed ID: 2476603
[TBL] [Abstract][Full Text] [Related]
11. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
12. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.
Smits GJ; McGraw DE; Trapani AJ
Am J Physiol; 1990 May; 258(5 Pt 2):F1417-24. PubMed ID: 2140018
[TBL] [Abstract][Full Text] [Related]
13. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).
Angus RM; Millar EA; Chalmers GW; Thomson NC
Thorax; 1996 Jan; 51(1):71-4. PubMed ID: 8658373
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction.
Angus RM; Millar EA; Chalmers GW; Thomson NC
Am J Respir Crit Care Med; 1995 Jun; 151(6):2003-5. PubMed ID: 7767551
[TBL] [Abstract][Full Text] [Related]
17. Renal responses to atrial natriuretic peptide are preserved in bilateral ureteral obstruction and augmented by neutral endopeptidase inhibition.
Ryndin I; Gulmi FA; Chou SY; Mooppan UM; Kim H
J Urol; 2005 Feb; 173(2):651-6. PubMed ID: 15643282
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recombinant atrial natriuretic peptide (r-ANP) on ischemic and cyclosporine-induced kidney damage in rats].
Yoshida K; Kagebayashi Y; Saka T; Yoneda T; Tani M; Ota M; Okajima E; Ozono S; Hirao Y; Okajima E
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):123-9. PubMed ID: 8139144
[TBL] [Abstract][Full Text] [Related]
19. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.
Maki T; Horio T; Yoshihara F; Suga S; Takeo S; Matsuo H; Kangawa K
Br J Pharmacol; 2000 Nov; 131(6):1204-10. PubMed ID: 11082129
[TBL] [Abstract][Full Text] [Related]
20. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
